Intended for healthcare professionals

Student Reviews

Minerva: October 2001

BMJ 2001; 323 doi: https://doi.org/10.1136/sbmj.0110398 (Published 01 October 2001) Cite this as: BMJ 2001;323:0110398
  1. Clifford R Weir, specialist registrar in ophthalmology1,
  2. A G Shabanni, specialist registrar in radiology1,
  3. P Duffy, consultant radiologist1,
  4. W Wykes, consultant ophthalmologist1,
  5. T Satyadas, research fellow2,
  6. C A Akle, consultant surgeon3
  1. 1Southern General Hospital, Glasgow G51 4TF
  2. 2university department of surgery, Royal Free Hospital, London NW3 2QG
  3. 3The London Clinic, London W1N 2DH

The challenge to clinicians caring for men with carcinoma of the prostate is to separate out those with low risk cancers who can simply be watched from those with high risk tumours who need early aggressive treatment. One useful measure (Mayo Clinic Proceedings 2001;76:571-2; 576-81) is the doubling time for the concentration of prostate specific antigen. It seems especially helpful in men whose disease has recurred: a long doubling time is associated with local recurrence whereas a short doubling time suggests systemic recurrence.

Soft drinks are often full of sugar, but cola drinks carry an additional health risk. A report in the Internal Medicine Journal (2001; 31:317-8) describes a patient with chronic caffeine toxicity manifesting as hypokalaemic myopathy. The patient presented with a year's history of muscle weakness, nausea, vomiting, diarrhoea. and weight loss. She admitted drinking 8 litres of cola every day for the past two years, amounting to at least 1 g of caffeine daily. Toxicity can occur at levels as low as …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription